Private placement of equity in FibroGen Europe Oy (FI) — FIM 57 million

Carnegie acted as sole manager in the private placement of equity in the European subsidiary, FibroGen Europe Oy, a company active within the field of medical devices and biomaterial development from recombinant collagen and gelatine.April, 1999.